FMS News and Press, Fresenius Medical Care AG From 08/18/22

The shares of Fresenius, one of the world's largest healthcare groups, have been in a downward and then a sideways trend since 2017. Corona pandemic has been a major challenge, especially for its subsidiary Fresenius Medical Care. Despite further waves of infection, the worst of the c...

Vifor Fresenius Medical Care Renal Pharma said that England's National Institute for Health and Care Excellence (NICE) recommended Tavneos in combination with a rituximab or cyclophosphamide regimen to treat adult patients with severe, active granulomatosis polyangiitis (GPA)...

Inflation and the better than feared earnings season dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. Inflation is softening in July and markets have started to rally again. U...

CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms PR Newswire Fresenius Medical Care and CytoSorbents have expanded their partnership via a multi-stage collaboration designed to seize new sales opportunitie...

Fresenius isn't just an undervalued aristocrat, it's a Buffett-style anti-bubble "fat pitch" that could deliver 235% returns in the next five years. Even with the Pandemic-induced downturn, FMS is expected to grow at 12% CAGR through 2027. If FMS grows as analysts expect by 2024 a...

Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...

Gainers: Better Therapeutics BTTX +43% . GeoVax Labs ( GOVX ) +22% . Aridis Pharmaceuticals ( ARDS ) +19% . Comera Life Sciences ( CMRA ) +13% . Gracell Biotechnologies ( GRCL ) +13% . Losers: Community Health Systems ( CYH ...

DaVita ( NYSE: DVA ) stock fell ~6% premarket July 28 after peer dialysis services provider Fresenius Medical Care ( FMS ) said it was cutting its outlook for FY22 due to increased headwinds from U.S. labor market and global inflation and also withdr...

Fresenius Medical Care ( NYSE: FMS ) stock fell ~13% premarket July 28 after the company said it was cutting its outlook for FY22 due to increased headwinds from U.S. labor market and global inflation, while also withdrawing its 2025 targets. The company also said th...

Fresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in Dialysis PR Newswire CombiSet SMARTECH™ Offers Innovative New Design and Simplifies Use WALTHAM, Mass. , July 27, 2022 /PRN...